PMC:7736111 / 51-607 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"3","span":{"begin":20,"end":25},"obj":"Disease"},{"id":"19","span":{"begin":98,"end":108},"obj":"Species"},{"id":"20","span":{"begin":151,"end":159},"obj":"Species"},{"id":"21","span":{"begin":185,"end":193},"obj":"Species"},{"id":"22","span":{"begin":502,"end":510},"obj":"Species"},{"id":"27","span":{"begin":85,"end":94},"obj":"Disease"},{"id":"28","span":{"begin":142,"end":150},"obj":"Disease"},{"id":"29","span":{"begin":493,"end":501},"obj":"Disease"}],"attributes":[{"id":"A3","pred":"tao:has_database_id","subj":"3","obj":"MESH:D003643"},{"id":"A19","pred":"tao:has_database_id","subj":"19","obj":"Tax:2697049"},{"id":"A20","pred":"tao:has_database_id","subj":"20","obj":"Tax:9606"},{"id":"A21","pred":"tao:has_database_id","subj":"21","obj":"Tax:9606"},{"id":"A22","pred":"tao:has_database_id","subj":"22","obj":"Tax:9606"},{"id":"A27","pred":"tao:has_database_id","subj":"27","obj":"MESH:D007239"},{"id":"A28","pred":"tao:has_database_id","subj":"28","obj":"MESH:C000657245"},{"id":"A29","pred":"tao:has_database_id","subj":"29","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"nts for Recovery or Death\n\nAbstract\nHyperactivation of the host immune system during infection by SARS-CoV-2 is the leading cause of death in COVID-19 patients. It is also evident that patients who develop mild/moderate symptoms and successfully recover display functional and well-regulated immune response. Whereas a delayed initial interferon response is associated with severe disease outcome and can be the tipping point towards immunopathological deterioration, often preceding death in COVID-19 patients. Further, adaptive immune response during COV"}

{"project":"LitCovid-sentences","denotations":[{"id":"T3","span":{"begin":27,"end":35},"obj":"Sentence"},{"id":"T4","span":{"begin":36,"end":160},"obj":"Sentence"},{"id":"T5","span":{"begin":161,"end":308},"obj":"Sentence"},{"id":"T6","span":{"begin":309,"end":511},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"nts for Recovery or Death\n\nAbstract\nHyperactivation of the host immune system during infection by SARS-CoV-2 is the leading cause of death in COVID-19 patients. It is also evident that patients who develop mild/moderate symptoms and successfully recover display functional and well-regulated immune response. Whereas a delayed initial interferon response is associated with severe disease outcome and can be the tipping point towards immunopathological deterioration, often preceding death in COVID-19 patients. Further, adaptive immune response during COV"}